Scinovex
review Open AccessTop 1% cited

Neuroinflammation and Central Sensitization in Chronic and Widespread Pain

Anesthesiology · 2018 · Vol. 129(2) · pp. 343–366
Ru‐Rong JiAndrea G. NackleyYul HuhNiccolò TerrandoWilliam Maixner

Abstract

Chronic pain is maintained in part by central sensitization, a phenomenon of synaptic plasticity, and increased neuronal responsiveness in central pain pathways after painful insults. Accumulating evidence suggests that central sensitization is also driven by neuroinflammation in the peripheral and central nervous system. A characteristic feature of neuroinflammation is the activation of glial cells, such as microglia and astrocytes, in the spinal cord and brain, leading to the release of proinflammatory cytokines and chemokines. Recent studies suggest that central cytokines and chemokines are powerful neuromodulators and play a sufficient role in inducing hyperalgesia and allodynia after central nervous system administration. Sustained increase of cytokines and chemokines in the central nervous system also promotes chronic widespread pain that affects multiple body sites. Thus, neuroinflammation drives widespread chronic pain via central sensitization. We also discuss sex-dependent glial/immune signaling in chronic pain and new therapeutic approaches that control neuroinflammation for the resolution of chronic pain.

Pain Mechanisms and TreatmentsStress Responses and CortisolNeuropeptides and Animal PhysiologyNeuroinflammationMedicineCentral nervous systemChronic painMicrogliaProinflammatory cytokineNeuroscienceSensitizationHyperalgesiaAllodynia

MeSH terms

AnalgesicsAnimalsClinical Trials as TopicGliosisHumansInflammationInflammation MediatorsCentral Nervous System SensitizationChronic PainPain Management
Citations
1,454
FWCI
47.94
field-weighted impact
References
296
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.